A detailed history of Palisade Capital Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Palisade Capital Management LLC holds 260,109 shares of RGEN stock, worth $42.9 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
260,109
Previous 245,455 5.97%
Holding current value
$42.9 Million
Previous $36.5 Million 2.5%
% of portfolio
1.2%
Previous 1.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$123.41 - $160.92 $1.81 Million - $2.36 Million
14,654 Added 5.97%
260,109 $37.4 Million
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $190,466 - $266,086
1,590 Added 0.65%
245,455 $36.5 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $7.1 Million - $10.8 Million
59,148 Added 32.02%
243,865 $30.7 Million
Q1 2024

May 15, 2024

SELL
$170.78 - $208.42 $7.5 Million - $9.16 Million
-43,933 Reduced 19.21%
184,717 $34 Million
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $2.37 Million - $3.84 Million
-20,733 Reduced 8.31%
228,650 $41.1 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $567,193 - $721,396
4,087 Added 1.67%
249,383 $39.7 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $1.38 Million - $1.8 Million
9,972 Added 4.24%
245,296 $34.7 Million
Q1 2023

May 08, 2023

BUY
$154.26 - $198.1 $806,779 - $1.04 Million
5,230 Added 2.27%
235,324 $39.6 Million
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $764,186 - $1.04 Million
-4,705 Reduced 2.0%
230,094 $39 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $18,769 - $29,976
117 Added 0.05%
234,799 $43.9 Million
Q2 2022

Aug 10, 2022

BUY
$140.68 - $188.02 $482,813 - $645,284
3,432 Added 1.48%
234,682 $38.1 Million
Q1 2022

May 09, 2022

SELL
$161.19 - $257.96 $2.74 Million - $4.39 Million
-17,018 Reduced 6.85%
231,250 $43.5 Million
Q4 2021

Feb 10, 2022

SELL
$247.59 - $304.47 $11 Million - $13.5 Million
-44,332 Reduced 15.15%
248,268 $65.8 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $949,114 - $1.58 Million
4,873 Added 1.69%
292,600 $84.6 Million
Q2 2021

Aug 12, 2021

SELL
$165.87 - $220.95 $993,229 - $1.32 Million
-5,988 Reduced 2.04%
287,727 $57.4 Million
Q1 2021

May 12, 2021

BUY
$180.37 - $226.26 $1.98 Million - $2.49 Million
10,997 Added 3.89%
293,715 $57.1 Million
Q4 2020

Feb 11, 2021

SELL
$148.08 - $206.57 $8.66 Million - $12.1 Million
-58,479 Reduced 17.14%
282,718 $54.2 Million
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $1.63 Million - $2.1 Million
13,271 Added 4.05%
341,197 $50.3 Million
Q2 2020

Aug 06, 2020

BUY
$94.33 - $140.48 $111,969 - $166,749
1,187 Added 0.36%
327,926 $40.5 Million
Q1 2020

May 13, 2020

SELL
$84.96 - $109.14 $6.18 Million - $7.94 Million
-72,757 Reduced 18.21%
326,739 $31.5 Million
Q4 2019

Feb 04, 2020

SELL
$73.84 - $93.08 $56,561 - $71,299
-766 Reduced 0.19%
399,496 $37 Million
Q3 2019

Nov 06, 2019

SELL
$76.65 - $95.51 $1.65 Million - $2.06 Million
-21,529 Reduced 5.1%
400,262 $30.7 Million
Q2 2019

Aug 06, 2019

SELL
$54.2 - $85.95 $4.29 Million - $6.8 Million
-79,077 Reduced 15.79%
421,791 $36.3 Million
Q1 2019

May 13, 2019

BUY
$49.45 - $62.8 $1.15 Million - $1.46 Million
23,174 Added 4.85%
500,868 $29.6 Million
Q4 2018

Feb 12, 2019

SELL
$48.26 - $68.88 $13.8 Million - $19.7 Million
-285,763 Reduced 37.43%
477,694 $25.2 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $6.89 Million - $8.68 Million
-147,247 Reduced 16.17%
763,457 $42.3 Million
Q2 2018

Aug 13, 2018

BUY
$35.26 - $47.04 $5.24 Million - $6.99 Million
148,660 Added 19.51%
910,704 $42.8 Million
Q1 2018

May 09, 2018

BUY
$30.92 - $37.27 $769,908 - $928,023
24,900 Added 3.38%
762,044 $27.6 Million
Q4 2017

Feb 09, 2018

BUY
$32.53 - $38.92 $2.54 Million - $3.04 Million
78,165 Added 11.86%
737,144 $26.7 Million
Q3 2017

Oct 31, 2017

BUY
$36.98 - $46.06 $24.4 Million - $30.4 Million
658,979
658,979 $25.3 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.14B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.